Induction immunochemotherapy followed by definitive chemoradiotherapy and consolidation immunotherapy for unresectable stage III non-small cell lung cancer: a multi-institutional retrospective cohort study

QR Code

Induction immunochemotherapy followed by definitive chemoradiotherapy and consolidation immunotherapy for unresectable stage III non-small cell lung cancer: a multi-institutional retrospective cohort study

BackgroundFor unresectable stage III non-small cell lung cancer (NSCLC), the standard regimen is definitive concurrent chemoradiotherapy (CRT) followed by consolidation immunotherapy. We investigated whether incorporating induction immunochemotherapy enhances the efficacy.Materials and methodsFrom J...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhixue Fu, Xin Dong, Jiawen Sun, Wei Deng, Yuting Zhao, Dan Yang, Leilei Jiang, Xiao Chang, Rong Yu, Anhui Shi, Huiming Yu, Jidong Wang, Wei Jiang, Jiawei Lu, Dongjie Chen, Jun Liang, Weihu Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	non-small cell lung cancer induction immunochemotherapy consolidation immunotherapy chemoradiotherapy real world
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1602082/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy?
by: Hsuan-Hsuan Yu, et al.
Published: (2021-06-01)

Chemoradiotherapy followed by continued immunotherapy for out-of-field progression during consolidation in limited-stage SCLC: a case report
by: Ying Jiang, et al.
Published: (2025-07-01)

Long-term survival in advanced pulmonary large-cell neuroendocrine carcinoma after multi-line immunochemotherapy and anti-angiogenic therapy: a case report
by: Hongming Wang, et al.
Published: (2025-06-01)

Impact of duration of maintenance immunotherapy on the prognosis of locally advanced non-small cell lung cancer treated with chemoradiotherapy
by: HuiQi Fan, et al.
Published: (2025-07-01)

Case Report: Pathological complete response achieved with neoadjuvant immunochemotherapy in synchronous multiple gastric adenocarcinoma
by: Ya-hui Sun, et al.
Published: (2025-07-01)

Expression profile of immunophenotypic marker molecules on B-lymphocytes in patients with chronic lymphocytic leukemia at the stages of immunochemotherapy
by: O. N. Selyutina, et al.
Published: (2022-12-01)

Development and validation of a postoperative risk model for esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
by: Hai Zhang, et al.
Published: (2025-08-01)

The effect of the relative dose intensity of chemoradiotherapy on the effectiveness of therapy of locally advanced unresectable non-small cell lung cancer
by: A. E. Glukhareva, et al.
Published: (2024-03-01)

Palliative intraarterial chemoradiotherapy as a method of choice in the treatment of unresectable oropharyngeal tumors: a clinical case
by: R. V. Lutovinin, et al.
Published: (2021-01-01)

Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients
by: V. A. Titova, et al.
Published: (2014-08-01)

Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma
by: Qiuying An, et al.
Published: (2025-07-01)

Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy
by: A. S. Nozdricheva, et al.
Published: (2024-04-01)

Consolidation accounting /
by: Ma, Ronald
Published: (1991)

Mergers and consolidations : a corporate-finance approach /
by: Reinhardt, Uwe E.
Published: (1972)

Consolidated statements and group accounts /
Published: (1976)

Consolidated financial statements: concepts, issues and techniques /
by: Taylor, P. A.
Published: (1987)

Accounting for business consolidations /
by: Swindells, Darryl K.
Published: (1990)

The role of chemoradiotherapy in the treatment of neuroendocrine rectal cancer: case reports
by: S. S. Gordeev, et al.
Published: (2022-09-01)

Business combinations & consolidated financial statements /
by: Belcher, Finley E.
Published: (1983)

CHEMORADIOTHERAPY FOR ORAL CANCER USING HYPERFRACTIONATED RADIATION SCHEDULE
by: M. U. Radzhapova, et al.
Published: (2021-05-01)

Survival Impact of Adjuvant Chemoradiotherapy in Resected Pancreatic Cancer
by: Eyyüp ÇAVDAR, et al.
Published: (2025-06-01)

Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01)

Management strategy for rectal cancer patients with complete clinical response after chemoradiotherapy
by: A. A. Medvednikov, et al.
Published: (2025-03-01)

MRI IN THE ASSESSMENT OF TUMOR RESPONSE TO CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
by: N. G. Trukhacheva, et al.
Published: (2016-02-01)

State-of-the-art of one-dimensional consolidation
by: Lun, P. T. W.
Published: (1982)

Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report
by: Yuki Nakamura, et al.
Published: (2018-09-01)

Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
by: V. A. Grigorenko, et al.
Published: (2021-07-01)

A novel radiomics model combining GTVp, GTVnd, and clinical data for chemoradiotherapy response prediction in patients with advanced NSCLC
by: Ya Li, et al.
Published: (2025-07-01)

Fiscal Consolidation Start and its Determinants Analysis Within European Member Countries
by: Lucia Mihóková
Published: (2017-09-01)

Tactics of chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the pharynx with index of metastatic regional lymph nodes stage N3
by: S. B. Alieva, et al.
Published: (2021-08-01)

Automation application when forming the consolidated financial statements of holding
by: A. V. Busigina
Published: (2020-01-01)

Chemoradiotherapy effcacy in squamous cell rectal cancer: a propensity score matched analysis
by: V. V. Murzo, et al.
Published: (2023-09-01)

THE ANALYSIS OF IMPLEMENTATION OF THE CONSOLIDATED TAX SYSTEMS ABROAD
by: V. Alkaeva
Published: (2016-07-01)

Consolidation accounting in Australia : concepts and practice /
by: Ma, Ronald
Published: (1983)

PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-07-01)

CANCER-EMBRYONIC ANTIGEN IN PREDICTING THERAPEUTIC TUMOR PATHOMORPHISM AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH RECTAL CANCER
by: D. V. Erygin, et al.
Published: (2018-06-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

Music-Assisted Progressive Muscle Relaxation in Patients with Locally Advanced Gastric Cancer Undergoing Concurrent Chemoradiotherapy
by: Juwei Zhong, et al.
Published: (2025-05-01)

Personalized genotype-directed antitumor therapy for newly diagnosed diffuse large B-cell lymphoma: efficacy and toxicity of the R-CHOP-X protocol in a single-center, non-randomized, prospective clinical trial (first results)
by: M. A. Mingalimov, et al.
Published: (2024-12-01)

Patient-reported outcomes after chemoradiotherapy for anal cancer
by: Kathinka Schmidt Slørdahl, et al.
Published: (2025-07-01)